BackDr Reddy’s gets tentative nod for anti-inflammatory drug
1 min read
24 Dec 2007, 03:02 PM IST
Dr Reddy’s gets tentative nod for anti-inflammatory drug
Premium
PTI
New Delhi: India’s second largest drug firm Dr Reddy’s Laboratories Ltd has received a tentative approval from drug regulator US Food and Drug Administration for its anti-inflammatory drug pantoprazole sodium.
The approval is for pantoprazole sodium in extended release tablet form, according to information on USFDA website.
The drug is prescribed to heal a condition called erosive esophagitis (a severe inflammation of the passage to the stomach) brought on by a persistent back-flow of stomach acid.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!
Catch all the Corporate news and Updates on Live Mint.
Download The Mint News App to get Daily Market Updates & Live Business News.
More
Less
Published: 24 Dec 2007, 03:02 PM IST
Next Story
